5858 HORTON STREET #455, EMERYVILLE, CA
Market cap: $405.4M (12/18/2025)
Price: $8.68
Other Events
Kristian Humer Appointed CFO of 4D Molecular Therapeutics, Inc.
Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
4D Molecular Therapeutics Issues 8.39M Shares at $10.51 Each
4D Molecular Therapeutics Reports $372.2 Million in Cash as of September 30, ...
Collaboration Agreement with Otsuka for 4D-150 in APAC Markets
News, Articles of Incorporation
Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement